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Abstract: The potential of plasma applications medicine, the connections to 
nanotechnologies and the results obtained by our group are reviewed. A special 
issue in plasma medicine is the development of the plasma sources that would 
achieve non-equilibrium at atmospheric pressure in an atmospheric gas mixture 
with no or only marginal heating of the gas, and with desired properties and 
mechanisms that may be controlled. Our studies have shown that control of 
radicals or chemically active products of the discharge, such as ROS (reactive 
oxygen species) and/or NO, may be used to control the growth of the seeds. 
Simultaneously, a specially designed plasma needle and other sources were 
shown to be efficient to sterilize not only colonies of bacteria but also plank-
tonic samples (microorganisms protected by water) or bio films. Finally, it was 
shown that a plasma might induce differentiation of stem cells. Non-equilib-
rium plasmas may be used in detection of different specific markers in medi-
cine. For example proton transfer mass spectroscopy may be employed in the 
detection of volatile organic compounds without their dissociation and thus as a 
technique for instantaneous measurement of the presence of markers for nu-
merous diseases. 
Keywords: low temperature plasmas; plasma technologies; sterilization; func-
tionalization; stem cells.  
INTRODUCTION 
This paper provides a survey of current plasma medical research/applications 
in the context of nanotechnologies, in particular, some of the research that was 
realized in our laboratory. 
Low temperature, non-thermal or more precisely non-equilibrium plasmas 
have shown extraordinary range of applications and range of targets that may be 
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treated. Some of the applications, such as plasma etching for integrated circuit 
production plasma sources of light, gas lasers and deposition of thin films, have 
already shaped the existing civilization,1–5 some on the other hand promise to 
make a similar impact in the future. Medical applications are at the forefront of 
future technologies associated with low temperature plasmas and the most active 
front of present day research.6–9 
Non-thermal plasmas are being widely used in nano-technological and bio-
medical applications due to several distinctive properties.1,2,10,11 The key feature 
is that it is possible to achieve dramatic changes of surface chemistry at low tem-
peratures. Most of the generator power is absorbed by the electrons in the dis-
charge, which then become hot, typically of the order of 10000 K or more, while, 
at the same time, ions and neutral molecules maintain room temperature, or close 
to it. The gas composition, the electron energy distribution function and the cross 
sections for the dominant interactions between electrons and the background gas 
particles dictate the production of huge amounts of chemically active species. If 
the gas composition is chosen properly and if the applied fields are designed effi-
ciently and appropriately, the effects required by a certain application may be 
achieved while simultaneously fulfilling the criterion of maintaining a low tem-
perature of the background gas.12 
For the nano-technological applications, the main advantage is the aniso-
tropic ion bombardment of surfaces (Fig. 1). Namely, sheaths are formed near 
surfaces due to the difference in particle masses. These high field regions con-
veniently accelerate ions, often with no collisions, to allow (nearly) normal inci-
dence impacts at the surfaces, converting the potential energy in the sheath into 
kinetic energy at the surface.14 A normal incidence angle is a crucial factor for 
contact holes to be obtained and interconnects with high aspect ratios. It is 
thought that the technology of combined photolithography and plasma etching is 
the most widely employed nanotechnology (belonging to the top down group) 
ever since the barrier in miniaturization of 200 nm was broken. The present day 
resolution of 32 nm in manufacture and aspect ratios of up to 20 (and much 
smaller dimensions achieved in laboratories) truly challenge even the bottom up 
technologies.  
Furthermore, ion impacts on the sample surface are isolated because the time 
between impacts onto an area of ≈1 nm2 is about 10–3 s. This should be com-
pared to the time of 10–12 s required for the energy of a single impact to dissipate 
to the background heat. In unison, a single ion impact dissipates several hundreds 
of eV locally, which is sufficient to make a significant albeit localized modifica-
tion of the surface. A typical flux of 1017 ions cm–2 s–1, on average, dissipates 
power densities of the order of 1 W cm–2. Thus, significant local and superficial 
changes of the surface structure are obtained while the overall temperature is not 
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increased significantly. The point here is that the peak power is sufficiently high 
to break chemical bonds easily and to perform functionalization of the surface. 
 
Fig. 1. Schematics of anisotropic plasma etching in non-equilibrium plasmas. The bulk of the 
plasma produces low energy ions and somewhat higher energy electrons that produce new 
ions and chemically active radicals. The sheath slows down the electrons and accelerates the 
ions, thus giving them energies of the order of several 100 eV. Hence, when they hit the 
surface they do so at a right angle and they facilitate anisotropic etching without 
sidewall undercutting. Electrons hit the surface with an almost isotropic distribution. 
The combined effect of the ions and radicals is much greater than the sum 
of the individual effects of the two species.13 
It is also well known that the individual effects of ions and neutral chemi-
cally active species can be dramatically increased13 when they both impact sur-
faces. This kind of synergy of the plasma agents is another crucial property in 
nano-technological applications. 
Neutral, chemically active radicals are created in large numbers by electron-
impact dissociation in molecular gas plasmas. It could easily be assumed that the 
surface flux of reactive particles (density) scales with pressure but gas phase 
collisions and slower diffusion as well as three body processes, which may 
change the chemistry entirely, have to be taken into consideration. The higher 
fluxes of active particles are one of the main arguments for atmospheric pressure 
non-thermal plasma sources over the low-pressure sources. This was one of the 
driving forces towards replacing low-pressure plasmas with atmospheric pres-
sure/gas composition plasmas, together with the increased simplicity and de-
creased cost of atmospheric pressure systems. Thus, the needs of modern nano-
technologies gave impetus for the development of more efficient and varied at-
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mospheric pressure sources of low temperature plasmas. With the opportunity for 
such a development, a new front easily opened - that of medical applications. 
Another advantage of atmospheric pressure, non-equilibrium plasmas is, of 
course, the fact that most biomedical systems cannot be subjected to vacuum. 
Moreover, for most biomedical applications, the temperature of the background 
gas should not exceed 42 °C, when cell death due to the overheating is induced. 
Hence, the ultimate conditions for biomedical applications would be not to over-
heat the sample but rather to induce subtle and selective cell and tissue responses 
to the plasma-generated chemicals and other species. Similar to nano-technolo-
gical applications, but probably even more important is the understanding of the 
synergetic effects of the plasma agents, namely ions, electrons, electric fields and 
currents, light, neutrals, radicals and metastables. It can be concluded that com-
mon goals together with a common need for a localized synergistic effect of se-
veral agents drive the applications in both nanotechnologies and plasma medi-
cine. Sometimes plasma medical effects that may be observed over a larger area 
are in essence due to very localized and specific effects that are fully in tune with 
nanotechnologies, their criteria and needs. 
A BRIEF HISTORY OF PLASMA MEDICINE AND ITS CURRENT STATUS 
The history of atmospheric pressure plasma applications in medicine can be 
divided into several periods. The first generation of plasma devices dating back 
to 1900 were those when heat was mainly used for tissue removal (plasma cut-
ter). This period was followed by the second generation (since 1970) where ther-
mal plasma energy was used for the surface treatment of tissues (argon plasma 
coagulator). In addition, there were numerous associated applications such as 
those using dielectric barrier discharges (DBD) for water purification, electrosta-
tic precipitators to cleanse the air in hospitals and plasma activated hydrogen 
peroxide as sterilizer. At the same time, low-pressure plasmas were efficiently 
used in the early 1990s to sterilize equipment.15 The third generation commenced 
in the late 1990s when plasmas were used, mainly at atmospheric pressures, for 
surface treatment with charged particles, reactive UV photons and electric fields. 
The first commercial plasma devices date back to the beginning of the 20th 
century and those were aimed at surgery.16 At present, there are numerous 
surgical devices but one has to be aware of the distinction between whether a 
plasma is just a conducting medium between an electrode and the treated tissue 
while the effect is due to thermal heating that is the result of the passage of the 
current or whether the surgical effects are due to plasma-created particles and 
their interaction with the fields and surface. One of the most successful devices 
associated with surgical interventions are plasma related devices for stopping 
bleeding, both by thermal effects and/or by plasma influence on the surface. 
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These devices include the endoscopic usage of APC (argon plasma coagulation) 
developed in 1995.17 
Another front of medical applications that proved to be very successful ex-
panded from low pressures15 to atmospheric pressures in the late 90s. Very effi-
cient sterilization of bacteria Escherichia coli was demonstrated by Laroussi in 
1999 using a helium DBD.18 This line of studies was pursued either directly in 
Petri dishes19 or in planktonic samples (in liquid)20 or even in biofilms.21 More 
importantly, sterilization by a plasma was shown to be one of the benefits in the 
treatment of wounds.22 
In addition to sterilization, plasmas were shown to benefit proliferation of 
new cells and the removal of scar tissue.23 Thus, numerous wounds were treated 
including burns and chronic wounds, such as diabetic foot.23 One of the recent 
applications of microwave plasma applications in dermatology for the treatment 
of chronic wounds is the application of the plasma torch MicroPlaSter®.22 
In vitro treatment of cancer cells was demonstrated in 2007 using a floating 
electrode dielectric barrier discharge (FE-DBD) plasma.24. With this device, it 
was possible to induce programmed death of cells, so-called apoptosis. The 
Plasma acts directly on the cell without poisoning the solution in which they are 
located, even when the cells are covered with a medium. 
The ion source of a proton transfer mass spectrometer (PTR-MS) operates 
using a non-thermal plasma. PTR-MS, compared to other analyzing devices, is 
more sensitive and can detect volatile organic compounds (VOC) down to parts 
per trillion in real time sampling. Breath sampling and analysis can provide data 
on VOC for the early stage detection of various diseases, such as breast and lung 
cancer, diabetes etc. Breath is a very complex mixture of various organic com-
pounds.25 For lung cancer, VOC-31 (m/z = 31), tentatively protonated formalde-
hyde, and VOC-43 (m/z = 43), tentatively a fragment of protonated 2-propanol, 
were found at significantly higher concentrations in the breath of cancer patients 
than in the breath of the control group.26 One of the biomarkers for diabetes is 
acetone27 and its higher concentration in breath, as well as the dynamics of its 
removal can be an indicator for the disease. 
EXPERIMENTAL SETUP AND PROCEDURE 
The main reason for the application of plasmas in medicine is that they can 
replace old conventional procedures in surgery and wound sterilization. Another 
important feature is the simplicity and low production cost of these plasma de-
vices. Various plasma sources are used in plasma medicine, such as plasma jets, 
plasma needle, APC and FE-DBD (Fig. 2). Most of the plasma devices have low 
working gas temperatures because of the great non-equilibrium between the ener-
gies of the electrons and heavy particles. This feature is crucial for treatment without 
damaging the sample. In order to ignite and maintain a discharge at atmospheric 
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pressure, a noble gas is often used (usually helium or argon). The main role of 
the noble gas is to lower the breakdown voltage and with its flow, the treated area 
is also cooled. The complex chemistry and reactions in a plasma produce a unique 
mixture of particles, for instance atomic species, radicals, UV photons and elec-
trons, important for the efficiency of the treatment of a biological sample. In 
order to produce higher concentration of the reactive species, a mixture of the 
noble and a molecular gas, usually oxygen, can be used. 
 
Fig. 2. Photographs of several atmospheric plasma devices that are used in our laboratory for 
biomedical applications. From the top, a plasma jet, a micro atmospheric pressure plasma jet 
and a plasma needle are shown. 
In our laboratory, low-pressure plasma reactors are accessible that have been 
used mainly for the treatment of surfaces (textile, polymers, graphene, silicon 
dioxide surfaces, etc.). Atmospheric pressure non-equilibrium plasmas that are 
available include plasma needle, micro atmospheric pressure plasma jet, plasma 
jet (operating in the plasma bullet mode), corona and dielectric barrier discharge. 
Our principal plasma device that was used to date in the studies of plasma 
medicine is the plasma needle, which was first applied for the treatment of mam-
malian cells reported in 2003.28 The operating power was low and the frequency 
of the driving current was 13.56 MHz in atmosphere of helium. The plasma 
needle can be used for the treatment of small areas covered by cells. The plasma 
needle at higher power kills cells, usually causing necrosis, but at smaller powers 
either apoptosis may be induced or cells could be just separated. 
This plasma device was shown to be suitable for bacteria sterilization20 of 
bacteria colonies, planktonic samples and bio films. In addition, this source was 
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shown to be able to destroy cancer cells, affect but to a much lesser degree hu-
man stem cells and even cause differentiation of the stem cells.29 
DIAGNOSTICS OF PLASMAS 
In order to determine the pertinent plasma properties and optimize the de-
sired effects, we use several diagnostic methods. In principle, the basic electrical 
properties are determined by probes (including derivative probes for higher fre-
quencies that have been calibrated to determine the powers delivered to a plasma 
of less than 1 W). Optical emission spectroscopy is applied with a limited range 
of interesting effects that may be covered unless time resolved measurements are 
made. Spatial profiles of emission recorded by an ultra fast ICCD are employed 
to determine the time dependent anatomy of the discharge. Finally, a mass ana-
lyzer with triple differential pumping is employed, which enables sample ions or 
radicals from atmospheric pressure discharges to be sampled.30,31 
MECHANISMS 
The interactions between a plasma and cells are hard to investigate due to the 
complexity of both systems. A plasma is a cocktail of active agents (radicals, UV 
light, heat, ions, electric fields, energetic particles, etc.) with strong synergetic 
effects. The proper diagnostics and optimization of plasma treatment is of vital 
importance. On the other hand, the biological samples being treated have a com-
plex sub-structure of their own, so plasma usually targets and affects several of 
them if not all. The character and the selectivity of the interaction are determined 
by the plasma properties and the structure of the bio-sample. For example, UV 
light can easily penetrate and reach DNA introducing single and double strand 
breaks (directly and/or by creating radicals in the vicinity of the DNA).32 In the 
case of bacteria, the DNA is in the nucleoid and is circular while the eukaryotic 
cells have their DNA better protected in the nucleus. The same intensity of UV 
light exposure can lead to the destruction of bacteria without long-term effects on 
the eukaryotic cell, which is just one of the examples of the selectivity mecha-
nism. Other examples worth discussing can be drawn from the differences in the 
surface to volume ratios, the structure of cell walls, the existence of cell enzymes, 
etc.33 Bacteria have a higher surface to volume ratio meaning that the same dose 
of plasma exposure can be sufficient for deactivation while no negative effects to 
surrounding tissue is caused. The cell wall is usually directly exposed to the 
plasma treatment. Due to ion bombardment (or to the strong electric fields), pores 
are being created in the cell wall.34 Through these pores, the cell can exchange 
its content with the surrounding. The cell content can leak out and cause cell 
stress and eventually cell death, as often happens. Bacteria cell wall is made of 
polysaccharides. Eukaryotic cells have walls made of phospholipids. Exposed to 
the plasma, lipid peroxidation process occurs. In the process of peroxidation of 
polysaccharides and phospholipids, the presence of water is important as well as 
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the composition of the media surrounding the cells and the ions play a catalytic 
role. One of the products of the lipid peroxidation process of the cell wall is the 
malondialdehyde. Formed at the cell wall by the plasma, malondialdehyde can be 
transported to the vicinity of DNA where it can introduce DNA mutation.35 All 
this shows the indirect effects of the plasma as well as the complexity of the cell 
reactions. The enzymes are also able to regulate the stress dealt to the cell. They 
also regulate the cell radical levels, which on the other hand are massively pro-
duced by the plasma. The importance of reactive oxygen and nitrogen species 
through cell redox processes is evidently crucial but not sufficiently under-
stood.36 Some of the reactive oxygen species are listed in Table I.37 The balance 
between the free radicals and the antioxidants is necessary for proper cell func-
tioning. The conclusion is general and valid for plant cells also.37 
TABLE I. Reactive oxygen species, ROS37 
Radicals Non-radicals 
Superoxide, 2O   H2O2 
Hydroxyl, OH  Hypobromous acid, HOBr 
Hydroperoxyl, 2HO  
(protonated superoxide) Hypochlorous acid, HOCl 
Carbonate, 2CO   Ozone, O3 
Peroxyl, 2RO  Singlet oxygen ( 12 gO  ) 
Alkoxyl, RO  Organic peroxides, ROOH 
Carbon dioxide radical, 2CO   Peroxynitrite, ONOO 
Singlet 12 gO   Peroxynitrate, O2NOO 
PARALLELS WITH PLASMA NANOTECHNOLOGIES 
Plasmas have been used in top down plasma technologies for many years, 
especially through synergistic process of plasma etching that is presently mas-
sively used in production with resolutions of 32 nm. Several plasma applications 
in nanotechnology may be associated with medicine. These include coating of 
biocompatible thin films, functionalization of surfaces to allow binding of bacte-
ricidal nanoparticles of TiO2 or silver, thus allowing the development of germ 
free clothes for surgeons and other medical personnel.38–45 
Furthermore, a more direct parallel lies in the fact that most plasma medical 
processes are very local over areas that are small parts of a cell and thus compa-
tible with nano-dimensions. Besides the plasma needle and micro atmospheric 
pressure plasma jet, the capillary microplasmas used for nanostructuring have 
similar potentials for biomedical applications.46,47 In a similar way, non-equilib-
rium plasmas are used to achieve thermodynamically unlikely structures/effects 
and in the same way surfaces are bombarded by a cocktail of ions and neutrals, 
electrons, chemically active radicals and are subjected to the effects of local 
fields. Finally, the need for atmospheric pressure for plasma medicine is also a 
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motivating factor for the development of cheaper nano-technologies not employ-
ing expensive vacuum procedures. Thus, the development of plasma medicine 
may be associated with the advances in non-equilibrium plasmas for micro 
(nano) electronics that have occurred over the past two decades. 
CONCLUSIONS 
Recent advances in plasma medical applications have left very little doubt 
that this application will be the main driving force for the future developments of 
non-equilibrium collisional plasmas. The main trick in achieving the non-equilib-
rium operation and no gas heating is the control of the electron multiplication. 
For this purpose, inhomogeneous fields (corona), dielectric barrier, RF and 
pulsed operation and breakdown in rare gas flow may be employed. 
Plasma medicine is a new and fast developing field of both medicine and 
plasma physics, introduced in the last decade. The non-thermal atmospheric pres-
sure plasmas were recently used for the treatment of diverse thermo sensitive 
biological samples. 
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У овом раду дат je преглед примене плазме у медицини, повезаност са нанотехно-
логијама и резултате на овом пољу које је постигла наша група. Посебан проблем у 
плазма медицини је развој извора плазме који би радили у неравнотежним условима на 
атмосферском притиску и у смеши гасова каква је у атмосфери уз занемарљиво грејање 
гаса и са жељеним карактеристикама које се могу подешавати по жељи. Наша истражи-
вања су показала да се контрола присуства радикала и других хемијски активних чес-
тица као што су реактивне кисеоничне честице (ROS) и/или NO, може користити за 
контролу клијања семенки. У исто време је доказано за посебно конструисану плазма 
иглу да може ефикасно да стерилише не само колоније бактерија већ и планктонске 
узорке (микроорганизме заштићене водом) па и биофилмове. На крају, ми смо показали 
да плазма може да индукује диференцијацију матичних ћелија. Неравнотежна плазма се 
може користити за детекцију разних специфичних маркера у медицини. На пример ма-
сена спектроскопија на бази измене протона може да се користи за детекцију испаривих 
органских једињења без њихове дисоцијације и на тај начин се може оставрити тренутна 
детекција маркера за бројне болести из даха. 
(Примљено 20. октобра, ревидирано 10. децембра 2012) 
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